Bilfinger Berger has won a €30m ($43m) contract to help Genzyme add 8,000L of production capacity at its site in Geel, Belgium.
Genzyme began work on the €250m production plant in January to add capacity to support the long-term growth of Myozyme (alglucosidase alfa). Having previously performed work for Sanofi, Genzyme’s new owner, Bilfinger Berger Industrial Services (BIS) has picked up the Geel deal.
